	Risk factors for shorter recurrence-free survival in patients with resected biliary tract cancer treated with adjuvant S-1 chemotherapy. Int J Clin Oncol Taira T, Sasaki M, Igarashi G, Inoue K, Shibuki T, Satake T, Amisaki M, Takahashi H, Imaoka H, Mitsunaga S, Kudo M, Sugimoto M, Kobayashi S, Gotohda N, Ikeda M. PMID: 42842179 [PubMed - as supplied by publisher]
	Have we gotten better at diagnosing PDAC before it is too late?: Temporal trends in stage at diagnosis of pancreatic ductal adenocarcinoma in the United States. Cancer Causes Control Hauptschein D, Kang P, Amar S. PMID: 42842045 [PubMed - indexed for MEDLINE]
	Development and External Validation of a Multimodal Machine Learning Model Integrating Preoperative Contrast-Enhanced CT Radiomics and Clinicopathological Features for Predicting Early Extrahepatic Recurrence After Hepatectomy for Hepatocellular Carcinoma. J Hepatocell Carcinoma Li Y, Luo X, Li Q, Wang Y, Zhang J, Li Y, Li B, Jiang K, Yang X. PMID: 42841025 [PubMed]
	Antigen-Presenting Cancer-Associated Fibroblasts Modulate Tumor Microimmunity. JMA J Fukui Y, Kasashima H, Naito N, Wang Z, Omori I, Seki Y, Shibutani M, Muta Y, Nakanishi Y, Yashiro M, Ohtani N, Maeda K. PMID: 42840554 [PubMed]
	The CGRP-nociceptor axis in cancer: tumor-specific programs of immune evasion, stromal remodeling, and tumor growth. Front Oncol Hua Y, Liu Y, Wang B, Liu Y, Tian X, Liu F, Tian Q, Yin F. PMID: 42840415 [PubMed]
	Preoperative Patient-reported Physical Functioning and Postoperative Wearable-measured Physical Activity in Cancer Patients: A Secondary Analysis of the SCRUM-MONSTAR LIFELOG Study. JMA J Yajima S, Kobayashi S, Hashimoto T, Nakamura Y, Yamashita R, Misumi T, Sakamoto Y, Fujisawa T, Imai M, Shibuki T, Bando H, Masuda H, Oki E, Yoshino T. PMID: 42840413 [PubMed]
	Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications. Front Epigenet Epigenom Sultana H, Solomon AD, Wani AK, Shukla SK. PMID: 42840291 [PubMed]
	A novel clinical FIT model predicts prognosis of unresectable hepatocellular carcinoma treated with TACE combined with lenvatinib and PD-1 inhibitors therapy. Front Immunol Liao M, Wang Z, Wang X, Ai X, Song L, Song Y, Qin W, Wang K, Zhou Y, Liu F, Rao H. PMID: 42840156 [PubMed - indexed for MEDLINE]
	Aromatic amine exposure and bladder cancer: a review of recent advances in epidemiology, pathogenesis, and prevention. Front Cell Dev Biol Li S, Zhang Y, Mao T, Wei J, Zhang W, Zhang J, Wei W. PMID: 42840084 [PubMed]
	An inflammation-nutrition-surgery-based INSEP model and a web-based clinical decision support system for predicting early postoperative infection in elderly patients with hepatocellular carcinoma: a multicenter retrospective study. Front Nutr Shao GZ, Hao DD, Luo FX, Zhang DS, Wu QZ, Fan GT, Zheng HT, Song SF, Qiu W, Chen YG. PMID: 42840030 [PubMed]
	Serous cystadenocarcinoma of the pancreas: a population-based study. World J Surg Oncol Dotevall T, Kolmodin E, Thylefors E, Andersson R, Ansari D. PMID: 42839234 [PubMed - indexed for MEDLINE]
	Revolutionizing Pancreatic Cancer Detection: The Role of AI-Integrated Biosensors in Early Diagnostics. Adv Biochem Eng Biotechnol Hooda A, Alhusseini JA, Basak R, Hu C. PMID: 42839080 [PubMed - as supplied by publisher]
	Short-term risk prediction model for pancreatic cancer in type 2 diabetes: development and validation across two independent Chinese cohorts. Gut Zhu H, Fan H, Yang W, Gao S, Chang J, Zong G, Zhuang Y, Abudukeranmu A, Jia X, Zhu Y, Zhang Y, Rong Z, Yang Y, Wu Z, Li M, Wang X, Zhang T, Song Z, Hao J. PMID: 42838738 [PubMed - as supplied by publisher]
	Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A/MMP9 axis: An integrated bioinformatics and experimental study. Pathol Res Pract Yang Y, Chen J, Xiao S, Du X, Liu X. PMID: 42837803 [PubMed - as supplied by publisher]
	Incidence and early prediction of post-operative pancreatic fistula after splenectomy in ovarian cancer cytoreduction within an enhanced recovery after surgery pathway: the ERASPLEEN study. Int J Gynecol Cancer D'Indinosante M, Bizzarri N, Zampolini Faustini A, Giannarelli D, Costantini B, Naldini A, Santullo F, Lodoli C, Cintoni M, Fanfani F, Fagotti A. PMID: 42837708 [PubMed - as supplied by publisher]
	Gastrointestinal symptoms and health-related quality of life before and after pancreatectomy for pancreatic cancer (GO-PANC): longitudinal nationwide study. Br J Surg Vissers PAJ, Schoorlemmer A, Pek CJ, Appelhof P, Baade-Corpelijn L, Betten E, Serlier-Erades L, de Groot H, Hoogendoorn-de Ruiter MW, Linders SAG, Reeves JL, Roele-de Vreugd AM, Roza-van Os PAW, Sterk ALA, van der Werf R, Besselink MGH, van Laarhoven HWM, van Eijck CHJ, Dutch Cancer Pancreatic Group. PMID: 42837495 [PubMed - indexed for MEDLINE]
	Targeting RAS in pancreatic cancer. Cancer Petrelli F, Dottorini L, Zaniboni A. PMID: 42836673 [PubMed - indexed for MEDLINE]
	Impact of Liver Metastases on Outcomes With Chemotherapy or Immune Checkpoint Inhibitors in Pancreatic Cancer. Immun Inflamm Dis Kjær LK, Theile S, Madsen K, Johansen JS, Holmström MO, Andersen MH, Chen IM. PMID: 42836590 [PubMed - indexed for MEDLINE]
	The Dual Role of Piezo1 in Cancer: Mechanotransduction, Microenvironment Remodelling, and Therapeutic Opportunities. Drug Des Devel Ther Jiang H, Liu Y, Xue F, Sun H, Ji Y, Qi L. PMID: 42836163 [PubMed - indexed for MEDLINE]
	Unspecific clinical manifestations of insulinoma found in preoperative testing: a case report and narrative review. Front Endocrinol (Lausanne) Yu M, Ji X, Zheng P. PMID: 42835176 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 61768

Page 1 of 3089



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy